Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (6): 584-589.DOI: 10.3969/j.issn.1673-8640.2023.06.015
Previous Articles Next Articles
WU Youhong1, SONG Yunxiao2, ZHU Yong1(), GE Wen2, BIAN Xiaobo2, YUAN Wenhua2, ZHAO Zhiyun2
Received:
2022-03-28
Revised:
2023-04-07
Online:
2023-06-30
Published:
2023-08-22
CLC Number:
WU Youhong, SONG Yunxiao, ZHU Yong, GE Wen, BIAN Xiaobo, YUAN Wenhua, ZHAO Zhiyun. Role of blood lipid levels in assessment of coronary artery stenosis and its treatment in patients with coronary heart disease[J]. Laboratory Medicine, 2023, 38(6): 584-589.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.06.015
组别 | 例数 | 年龄/岁 | 性别 | BMI/ (kg/m2) | TC/ (mmol/L) | TG/ (mmol/L) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女[例(%)] | ||||||
Ⅰ级组 | 80 | 77.67±12.14 | 53(66.25) | 27(33.75) | 24.31±4.01 | 2.66±0.58 | 1.11±0.56 |
Ⅱ级组 | 137 | 75.33±12.13 | 86(62.78) | 51(37.22) | 24.22±3.40 | 3.37±0.54** | 1.25±0.54** |
Ⅲ级组 | 204 | 75.41±11.94 | 96(47.06) | 108(52.94) | 23.38±3.36 | 4.26±0.53**### | 1.53±0.88**## |
Ⅳ级组 | 49 | 73.45±10.76 | 15(30.61) | 34(69.39) | 23.95±3.51 | 5.69±1.07**###△ | 1.97±1.26**##△ |
统计值 | 0.792 | 23.646 | 2.203 | 300.400 | 15.090 | ||
P值 | 0.248 | <0.001 | 0.088 | <0.001 | <0.001 | ||
组别 | HDL-C/(mmol/L) | LDL-C/(mmol/L) | apo A1/(g/L) | apo B/(g/L) | Lp(a)/(g/L) | ||
Ⅰ级组 | 1.27±0.38 | 1.30±0.43 | 1.15±0.25 | 0.53±0.17 | 0.11(0.01~0.26) | ||
Ⅱ级组 | 1.20±0.36** | 1.76±0.45** | 1.26±0.22* | 0.70±0.17** | 0.17(0.06~0.38)** | ||
Ⅲ级组 | 1.11±0.30**# | 2.39±0.44**### | 1.36±0.40*# | 0.94±0.17**### | 0.26(0.10~0.43)**### | ||
Ⅳ级组 | 0.97±0.24**##△ | 3.42±0.82**###△ | 1.50±0.66*#△ | 1.30±0.32**###△ | 0.27(0.14~0.54)**### | ||
统计值 | 10.570 | 231.100 | 11.170 | 208.200 | 15.590 | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | 年龄/岁 | 性别 | BMI/ (kg/m2) | TC/ (mmol/L) | TG/ (mmol/L) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女[例(%)] | ||||||
Ⅰ级组 | 80 | 77.67±12.14 | 53(66.25) | 27(33.75) | 24.31±4.01 | 2.66±0.58 | 1.11±0.56 |
Ⅱ级组 | 137 | 75.33±12.13 | 86(62.78) | 51(37.22) | 24.22±3.40 | 3.37±0.54** | 1.25±0.54** |
Ⅲ级组 | 204 | 75.41±11.94 | 96(47.06) | 108(52.94) | 23.38±3.36 | 4.26±0.53**### | 1.53±0.88**## |
Ⅳ级组 | 49 | 73.45±10.76 | 15(30.61) | 34(69.39) | 23.95±3.51 | 5.69±1.07**###△ | 1.97±1.26**##△ |
统计值 | 0.792 | 23.646 | 2.203 | 300.400 | 15.090 | ||
P值 | 0.248 | <0.001 | 0.088 | <0.001 | <0.001 | ||
组别 | HDL-C/(mmol/L) | LDL-C/(mmol/L) | apo A1/(g/L) | apo B/(g/L) | Lp(a)/(g/L) | ||
Ⅰ级组 | 1.27±0.38 | 1.30±0.43 | 1.15±0.25 | 0.53±0.17 | 0.11(0.01~0.26) | ||
Ⅱ级组 | 1.20±0.36** | 1.76±0.45** | 1.26±0.22* | 0.70±0.17** | 0.17(0.06~0.38)** | ||
Ⅲ级组 | 1.11±0.30**# | 2.39±0.44**### | 1.36±0.40*# | 0.94±0.17**### | 0.26(0.10~0.43)**### | ||
Ⅳ级组 | 0.97±0.24**##△ | 3.42±0.82**###△ | 1.50±0.66*#△ | 1.30±0.32**###△ | 0.27(0.14~0.54)**### | ||
统计值 | 10.570 | 231.100 | 11.170 | 208.200 | 15.590 | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
项目 | Ⅰ级 | Ⅱ级 | Ⅲ级 | Ⅳ级 | |||||
---|---|---|---|---|---|---|---|---|---|
OR①值(95%CI②) | P值 | OR①值(95%CI②) | P值 | OR①值(95%CI②) | P值 | ||||
性别 | 1.0 | 0.58(0.24~1.38) | 0.220 | 0.49(0.18~1.32) | 0.160 | 0.61(0.15~2.45) | 0.480 | ||
TC | 1.0 | 0.71(0.03~16.91) | 0.830 | 22.83(1.15~45.25) | 0.040 | 22.50(3.97~114.56) | 0.001 | ||
TG | 1.0 | 2.61(1.06~6.35) | 0.040 | 3.16(1.26~7.94) | 0.010 | 1.93(0.60~6.19) | 0.270 | ||
HDL-C | 1.0 | 0.79(0.46~0.92) | 0.002 | 0.65(0.42~0.87) | 0.002 | 0.61(0.16~1.81) | 0.250 | ||
LDL-C | 1.0 | 48.59(1.39~169.98) | 0.030 | 15.99(1.28~200.28) | 0.030 | 6.32(0.28~140.66) | 0.240 | ||
apo A1 | 1.0 | 0.30(0.08~1.05) | 0.060 | 0.27(0.09~0.80) | 0.020 | 0.23(0.04~1.37) | 0.110 | ||
apo B | 1.0 | 13.21(0.01~121.46) | 0.470 | 37.29(0.01~101.59) | 0.370 | 0.31(0.00~98.21) | 0.830 | ||
Lp(a) | 1.0 | 3.45(0.38~31.36) | 0.270 | 9.41(0.84~105.57) | 0.070 | 7.99(0.47~136.15) | 0.150 |
项目 | Ⅰ级 | Ⅱ级 | Ⅲ级 | Ⅳ级 | |||||
---|---|---|---|---|---|---|---|---|---|
OR①值(95%CI②) | P值 | OR①值(95%CI②) | P值 | OR①值(95%CI②) | P值 | ||||
性别 | 1.0 | 0.58(0.24~1.38) | 0.220 | 0.49(0.18~1.32) | 0.160 | 0.61(0.15~2.45) | 0.480 | ||
TC | 1.0 | 0.71(0.03~16.91) | 0.830 | 22.83(1.15~45.25) | 0.040 | 22.50(3.97~114.56) | 0.001 | ||
TG | 1.0 | 2.61(1.06~6.35) | 0.040 | 3.16(1.26~7.94) | 0.010 | 1.93(0.60~6.19) | 0.270 | ||
HDL-C | 1.0 | 0.79(0.46~0.92) | 0.002 | 0.65(0.42~0.87) | 0.002 | 0.61(0.16~1.81) | 0.250 | ||
LDL-C | 1.0 | 48.59(1.39~169.98) | 0.030 | 15.99(1.28~200.28) | 0.030 | 6.32(0.28~140.66) | 0.240 | ||
apo A1 | 1.0 | 0.30(0.08~1.05) | 0.060 | 0.27(0.09~0.80) | 0.020 | 0.23(0.04~1.37) | 0.110 | ||
apo B | 1.0 | 13.21(0.01~121.46) | 0.470 | 37.29(0.01~101.59) | 0.370 | 0.31(0.00~98.21) | 0.830 | ||
Lp(a) | 1.0 | 3.45(0.38~31.36) | 0.270 | 9.41(0.84~105.57) | 0.070 | 7.99(0.47~136.15) | 0.150 |
组别 | 例数 | 年龄/岁 | 性别 | BMI/(kg/m2) | TC/(mmol/L) | TG/(mmol/L) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | ||||||
非治疗组 | 210 | 76.19±12.16 | 135(64.29) | 75(35.71) | 24.25±3.63 | 3.10±0.65 | 1.20±0.55 |
治疗组 | 260 | 75.03±11.72 | 115(44.23) | 145(55.77) | 23.49±3.39 | 4.53±0.87 | 1.61±0.98 |
统计值 | 1.049 | 18.766 | 2.341 | 19.77 | 5.413 | ||
P值 | 0.293 | <0.001 | 0.019 | <0.001 | <0.001 | ||
组别 | HDL-C/(mmol/L) | LDL-C/(mmol/L) | apo A1/(g/L) | apo B/(g/L) | Lp(a)/(g/L) | ||
非治疗组 | 1.21±0.36 | 1.59±0.49 | 1.22±0.24 | 0.64±0.19 | 0.15(0.03~0.31) | ||
治疗组 | 1.06±0.29 | 2.59±0.67 | 1.39±0.46 | 1.01±0.25 | 0.24(0.12~0.48) | ||
统计值 | 5.003 | 18.07 | 4.848 | 17.71 | 4.308 | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | 年龄/岁 | 性别 | BMI/(kg/m2) | TC/(mmol/L) | TG/(mmol/L) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | ||||||
非治疗组 | 210 | 76.19±12.16 | 135(64.29) | 75(35.71) | 24.25±3.63 | 3.10±0.65 | 1.20±0.55 |
治疗组 | 260 | 75.03±11.72 | 115(44.23) | 145(55.77) | 23.49±3.39 | 4.53±0.87 | 1.61±0.98 |
统计值 | 1.049 | 18.766 | 2.341 | 19.77 | 5.413 | ||
P值 | 0.293 | <0.001 | 0.019 | <0.001 | <0.001 | ||
组别 | HDL-C/(mmol/L) | LDL-C/(mmol/L) | apo A1/(g/L) | apo B/(g/L) | Lp(a)/(g/L) | ||
非治疗组 | 1.21±0.36 | 1.59±0.49 | 1.22±0.24 | 0.64±0.19 | 0.15(0.03~0.31) | ||
治疗组 | 1.06±0.29 | 2.59±0.67 | 1.39±0.46 | 1.01±0.25 | 0.24(0.12~0.48) | ||
统计值 | 5.003 | 18.07 | 4.848 | 17.71 | 4.308 | ||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
项目 | 模型1① | 模型2② | 模型3③ | |||||
---|---|---|---|---|---|---|---|---|
OR值(95%CI) | P值 | OR值(95%CI) | P值 | OR值(95%CI) | P值 | |||
TC | 27.52(14.95~50.64) | <0.001 | 28.42(15.21~53.11) | <0.001 | 28.42(15.21~53.11) | <0.001 | ||
TG | 2.18(1.62~2.94) | <0.001 | 2.35(1.70~3.23) | <0.001 | 2.36(1.72~3.25) | <0.001 | ||
HDL-C | 0.25(0.03~0.48) | <0.001 | 0.33(0.08~0.62) | 0.006 | 0.32(0.11~0.59) | 0.006 | ||
LDL-C | 33.05(17.51~62.35) | <0.001 | 31.03(20.57~61.85) | <0.001 | 41.56(18.07~85.82) | <0.001 | ||
apo A1 | 11.20(4.82~26.03) | <0.001 | 7.26(3.03~17.40) | <0.001 | 7.26(3.03~17.40) | <0.001 | ||
apo B | 64.12(13.64~320.11) | <0.001 | 10.12(8.48~15.75) | <0.001 | 11.12(8.48~15.77) | <0.001 | ||
Lp(a) | 5.95(2.36~15.05) | 0.002 | 5.84(2.27~14.99) | 0.002 | 5.98(2.30~15.53) | 0.002 |
项目 | 模型1① | 模型2② | 模型3③ | |||||
---|---|---|---|---|---|---|---|---|
OR值(95%CI) | P值 | OR值(95%CI) | P值 | OR值(95%CI) | P值 | |||
TC | 27.52(14.95~50.64) | <0.001 | 28.42(15.21~53.11) | <0.001 | 28.42(15.21~53.11) | <0.001 | ||
TG | 2.18(1.62~2.94) | <0.001 | 2.35(1.70~3.23) | <0.001 | 2.36(1.72~3.25) | <0.001 | ||
HDL-C | 0.25(0.03~0.48) | <0.001 | 0.33(0.08~0.62) | 0.006 | 0.32(0.11~0.59) | 0.006 | ||
LDL-C | 33.05(17.51~62.35) | <0.001 | 31.03(20.57~61.85) | <0.001 | 41.56(18.07~85.82) | <0.001 | ||
apo A1 | 11.20(4.82~26.03) | <0.001 | 7.26(3.03~17.40) | <0.001 | 7.26(3.03~17.40) | <0.001 | ||
apo B | 64.12(13.64~320.11) | <0.001 | 10.12(8.48~15.75) | <0.001 | 11.12(8.48~15.77) | <0.001 | ||
Lp(a) | 5.95(2.36~15.05) | 0.002 | 5.84(2.27~14.99) | 0.002 | 5.98(2.30~15.53) | 0.002 |
[1] | 艾聪, 李娟, 张珊姗, 等. 辽宁农村地区2009—2015年冠心病死亡趋势及早死所致疾病负担研究[J]. 中华疾病控制杂志, 2018, 22(11):1106-1109. |
[2] | 中华医学会老年医学分会老年神经病学组, 北京神经科学学会血管神经病学专业委员会, 动脉粥样硬化性缺血性卒中/短暂性脑缺血发作合并冠心病诊治中国专家共识编写组. 动脉粥样硬化性缺血性卒中/短暂性脑缺血发作合并冠心病诊治中国专家共识(2022)[J]. 中华医学杂志, 2022, 102(45):3569-3580. |
[3] | 张冠龙, 浮志坤, 马云飞, 等. 脂质变化与性别交互作用对老年内膜增生的关联研究[J]. 中华老年心脑血管病杂志, 2021, 23(11):1146-1149. |
[4] | 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5):390-419. |
[5] | 梁启权, 谢志辉, 曾胜宏, 等. 老年女性冠心病患者血尿酸、低密度脂蛋白胆固醇水平与冠状动脉狭窄程度的相关性[J]. 吉林医学, 2022, 43(5):1207-1210. |
[6] |
FIHN S D, BLANKENSHIP J C, ALEXANDER K P, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,and the American Association for Thoracic Surgery,Preventive Cardiovascular Nurses Association,Society for Cardiovascular Angiography and Interventions,and Society of Thoracic Surgeons[J]. J Am Coll Cardiol, 2014, 64(18):1929-1949.
DOI URL |
[7] | 付琳. 冠心病患者载脂蛋白B/载脂蛋白A1、胱抑素C、血清胆红素水平变化与冠状动脉病变严重程度的相关性[D]. 太原: 山西医科大学, 2021. |
[8] | 许鸣笛, 汪莲开, 张莉, 等. 血脂异常与冠心病关系的研究进展[J]. 世界最新医学信息文摘, 2018, 18(16):149-150. |
[9] | 顾征璟, 尹元, 陆群. 冠心病患者血脂相关指标与冠状动脉狭窄的相关性分析[J]. 标记免疫分析与临床, 2022, 29(1):119-122. |
[10] | 王洁, 肖珉, 李玉峰, 等. 血脂和凝血指标与冠心病患者冠状动脉狭窄程度的相关性[J]. 中国医药, 2023, 18(1):11-15. |
[11] | 王琳琳, 范君, 叶陈宇, 等. 血脂与老年冠心病患者颈动脉粥样硬化斑块的相关性[J]. 检验医学, 2021, 36(6):618-622. |
[1] | MA Jianguo, LI Hongchun. Correlation between blood lipid levels and cardiac function indexes in patients with coronary heart disease [J]. Laboratory Medicine, 2023, 38(7): 659-664. |
[2] | JIN Suli, ZHAO Jing, ZHANG Jie, HOU Xuening, FANG Yanchao, YANG Li, MI Yujing. Relationship between thyroid hormones and bile acid subfractions and blood lipids in Graves' disease patients [J]. Laboratory Medicine, 2023, 38(6): 563-568. |
[3] | CHEN Zhe, ZHANG Ling, LIU Jie, WANG Xia, ZHANG Bin, GAO Binghua. Relationship between serum miR-326 and chemotherapy sensitivity and prognosis in patients with treatment-related hematological malignancy [J]. Laboratory Medicine, 2023, 38(3): 251-256. |
[4] | WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86. |
[5] | SHEN Jianguo, LI Tingting, SONG Yunxiao, BIAN Xiaobo, ZHANG Linlin, JIN Xiaoling. Clinical role of blood lipid in brittle fracture elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(6): 535-538. |
[6] | HUANG Wanhong, MO Lida, LUO Xiaolu, LIN Yinghui, LIU Zeduan, CHEN Songlin. Level changes of GM and BG in patients with IPA before and after treatment in different immune states [J]. Laboratory Medicine, 2022, 37(5): 443-446. |
[7] | SHANG Xipeng, LI Sha, DU Jinghui, LIU Xu. Research status of Actinotignum schaalii [J]. Laboratory Medicine, 2022, 37(4): 392-395. |
[8] | WU Wenping, XU Linjuan, WANG Jiaheng, ZHANG Nana. Correlation analysis of PBK/TOPK expression with treatment response and survival prognosis in elderly patients with acute myeloid leukemia [J]. Laboratory Medicine, 2022, 37(11): 1017-1022. |
[9] | PENG Yanjun, HAN Xuejing, TANG Hongxia, CHEN Junmeng, JIA Kegang. Correlation between nuclear magnetic resonance spectroscopy and traditional biochemical determination methods analyzer for determining blood lipid [J]. Laboratory Medicine, 2021, 36(7): 733-737. |
[10] | LIU Jinyan, ZHAO Juntao, XIANG Mingjie. Mechanism and application of serum amyloid A in clinical diseases [J]. Laboratory Medicine, 2021, 36(7): 756-760. |
[11] | ZHANG Guanyi, YAO Dongting, WANG Jian, HU Xiaobo. Research progress on Chinese and western medicine treatment for Candida glabrata infection [J]. Laboratory Medicine, 2021, 36(7): 761-765. |
[12] | DAI Yanpeng, YUAN Enwu, LIU Junjie, LI Yushan, WANG Quanxian. Analysis of the appropriate levels of blood lipid among healthy pregnant women in Zhengzhou [J]. Laboratory Medicine, 2021, 36(6): 604-608. |
[13] | LI Jing, QUAN Hui, ZENG Zhirong, WEI Yi. Establishment of the reference interval of small and dense low-density lipoprotein cholesterol in apparently healthy adults in Chengdu [J]. Laboratory Medicine, 2021, 36(6): 609-614. |
[14] | WANG Linlin, FAN Jun, YE Chenyu, YING Chunmei. Correlation between blood lipid and carotid atherosclerotic plaque in elderly patients with coronary heart disease [J]. Laboratory Medicine, 2021, 36(6): 618-622. |
[15] | KONG Fanbin, YUAN Yong, JI Yong, LI Zheng, CHEN Qi, WU Xiaoming, GAO Hui. Correlation between serum retinol binding protein 4,homocysteine and blood lipid with atherosclerosis [J]. Laboratory Medicine, 2021, 36(5): 467-470. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||